| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1473-3099(16)30385-1 |
| P698 | PubMed publication ID | 28159534 |
| P50 | author | Lisa Ng | Q22279398 |
| Ali Zaid | Q47098735 | ||
| Lara Herrero | Q47504472 | ||
| Suresh Mahalingam | Q55190793 | ||
| Alain Kohl | Q60956090 | ||
| Jonathan J Miner | Q66738963 | ||
| Adam Taylor | Q84145121 | ||
| Deborah J. Lenschow | Q85543822 | ||
| Felicity J Burt | Q88887992 | ||
| Penny A Rudd | Q115653680 | ||
| Andres Merits | Q24546306 | ||
| P2093 | author name string | Weiqiang Chen | |
| Esther Schnettler | |||
| P2860 | cites work | Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus | Q21090106 |
| A single mutation in chikungunya virus affects vector specificity and epidemic potential | Q21131599 | ||
| Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak | Q21144706 | ||
| Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism | Q21559402 | ||
| Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study | Q21562246 | ||
| Arthropod-borne viral infections of man in Nigeria, 1964–1970 | Q22330898 | ||
| Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine | Q24276414 | ||
| Genetic divergence of Chikungunya viruses in India (1963-2006) with special reference to the 2005-2006 explosive epidemic | Q42623122 | ||
| Transcontinental movement of Asian genotype chikungunya virus | Q42749140 | ||
| A226V strains of Chikungunya virus, Réunion Island, 2010. | Q42953154 | ||
| First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality! | Q43001209 | ||
| Betulin-derived compounds as inhibitors of alphavirus replication | Q43259109 | ||
| Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in mice | Q43658672 | ||
| A destructive arthropathy following Chikungunya virus arthritis--a possible association | Q44164039 | ||
| Development of an attenuated strain of chikungunya virus for use in vaccine production | Q44523303 | ||
| Prostratin and 12-O-tetradecanoylphorbol 13-acetate are potent and selective inhibitors of Chikungunya virus replication | Q44849183 | ||
| Morbidity and impaired quality of life 30 months after chikungunya infection: comparative cohort of infected and uninfected French military policemen in Reunion Island | Q44849348 | ||
| Interleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts | Q44849436 | ||
| Emergence and potential for spread of Chikungunya virus in Brazil | Q24288877 | ||
| Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages | Q24288996 | ||
| Chikungunya, an epidemic arbovirosis | Q24291001 | ||
| Chikungunya virus infection | Q24497757 | ||
| Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships | Q24570057 | ||
| Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling | Q24594497 | ||
| Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock | Q24598171 | ||
| Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff | Q24606603 | ||
| Four cases of acute flaccid paralysis associated with chikungunya virus infection | Q24616926 | ||
| Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II | Q24619991 | ||
| Chikungunya infection in travelers | Q24628887 | ||
| A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection | Q24631774 | ||
| Chikungunya: epidemiology | Q24701719 | ||
| New Insights into Control of Arbovirus Replication and Spread by Insect RNA Interference Pathways | Q24701745 | ||
| Mutations conferring a noncytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2 | Q24701750 | ||
| Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion | Q24701760 | ||
| Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection | Q24701763 | ||
| Functional cross-talk between distant domains of chikungunya virus non-structural protein 2 is decisive for its RNA-modulating activity | Q24701782 | ||
| CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis | Q24701793 | ||
| Alphavirus RNA synthesis and non-structural protein functions | Q24701805 | ||
| Viral infections in travellers from tropical Africa | Q27477517 | ||
| Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus | Q27487330 | ||
| The Crystal Structures of Chikungunya and Venezuelan Equine Encephalitis Virus nsP3 Macro Domains Define a Conserved Adenosine Binding Pocket | Q27488798 | ||
| Chikungunya Virus, Cameroon, 2006 | Q27489543 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity | Q28476579 | ||
| NTPase and 5'-RNA triphosphatase activities of Chikungunya virus nsP2 protein | Q28479203 | ||
| A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease | Q28533408 | ||
| Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library | Q28534763 | ||
| A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis | Q34703785 | ||
| Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1-226V isolates | Q34926408 | ||
| Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity | Q34927480 | ||
| Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes | Q34977748 | ||
| Chikungunya virus 3' untranslated region: adaptation to mosquitoes and a population bottleneck as major evolutionary forces | Q34979371 | ||
| Prophylaxis and therapy for Chikungunya virus infection | Q34990306 | ||
| Discovery of mosquito saliva microRNAs during CHIKV infection | Q35000969 | ||
| Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response | Q35023852 | ||
| Conservation of a packaging signal and the viral genome RNA packaging mechanism in alphavirus evolution | Q35140421 | ||
| BST2/tetherin inhibition of alphavirus exit | Q35544442 | ||
| A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection | Q35641902 | ||
| A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation | Q35675871 | ||
| Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus | Q35850197 | ||
| Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis | Q36114846 | ||
| A specific domain of the Chikungunya virus E2 protein regulates particle formation in human cells: implications for alphavirus vaccine design | Q36171996 | ||
| Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress | Q36318652 | ||
| Dephosphorylation of HuR protein during alphavirus infection is associated with HuR relocalization to the cytoplasm | Q36332866 | ||
| Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development | Q36397446 | ||
| A chimeric vesiculo/alphavirus is an effective alphavirus vaccine | Q36506753 | ||
| Chikungunya and the eye: a review | Q36707161 | ||
| Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine | Q36837548 | ||
| Molecular Characterization of Chikungunya Virus, Philippines, 2011-2013 | Q36884925 | ||
| A polarized cell model for Chikungunya virus infection: entry and egress of virus occurs at the apical domain of polarized cells | Q28539957 | ||
| Heat shock protein 90 positively regulates Chikungunya virus replication by stabilizing viral non-structural protein nsP2 during infection | Q28539964 | ||
| Infection with chikungunya virus in Italy: an outbreak in a temperate region | Q29346487 | ||
| An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features | Q29620004 | ||
| Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication | Q30009234 | ||
| The C-terminal repeat domains of nsP3 from the Old World alphaviruses bind directly to G3BP | Q30009448 | ||
| Sequestration of G3BP coupled with efficient translation inhibits stress granules in Semliki Forest virus infection | Q30009987 | ||
| SH3 domain-mediated recruitment of host cell amphiphysins by alphavirus nsP3 promotes viral RNA replication | Q30010201 | ||
| Chikungunya in the Americas | Q30080031 | ||
| US Military contributions to the global response to pandemic chikungunya | Q30224145 | ||
| A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates | Q30398956 | ||
| Production of virus-derived ping-pong-dependent piRNA-like small RNAs in the mosquito soma | Q31045021 | ||
| Tracking the re-emergence of epidemic chikungunya virus in Indonesia | Q31146393 | ||
| In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination | Q33195882 | ||
| Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients | Q33375141 | ||
| Mother-to-child transmission of Chikungunya virus infection | Q33376362 | ||
| Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies | Q33517926 | ||
| Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose. | Q33684369 | ||
| Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells | Q33744635 | ||
| Epidemiology, clinical manifestations, and diagnosis of Chikungunya fever: lessons learned from the re-emerging epidemic | Q33796693 | ||
| BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1) | Q33861091 | ||
| Neurocognitive outcome of children exposed to perinatal mother-to-child Chikungunya virus infection: the CHIMERE cohort study on Reunion Island | Q33916134 | ||
| Characterization of Aedes aegypti innate-immune pathways that limit Chikungunya virus replication | Q33945559 | ||
| Co-circulation of Dengue and Chikungunya Viruses, Al Hudaydah, Yemen, 2012. | Q33951110 | ||
| Guillain-Barré syndrome complicating a Chikungunya virus infection | Q34008392 | ||
| Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006. | Q34013185 | ||
| Acute Arboviral Infections in Guinea, West Africa, 2006 | Q34024894 | ||
| Species-specific impact of the autophagy machinery on Chikungunya virus infection | Q34036496 | ||
| Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging | Q34099818 | ||
| Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence | Q34102716 | ||
| Arthritogenic alphaviruses--an overview | Q34273343 | ||
| A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice | Q34315384 | ||
| Comparative pathogenesis of epidemic and enzootic Chikungunya viruses in a pregnant Rhesus macaque model | Q34341822 | ||
| Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response | Q34378105 | ||
| Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice | Q34394530 | ||
| Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model | Q37065242 | ||
| Chikungunya fever outbreak, Bhutan, 2012 | Q37261986 | ||
| Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis | Q37331952 | ||
| Antiviral treatment of chikungunya virus infection | Q37411581 | ||
| Next generation sequencing reveals regulation of distinct Aedes microRNAs during chikungunya virus development | Q37464859 | ||
| Atypical manifestations of chikungunya infection | Q37588903 | ||
| A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection. | Q37643733 | ||
| Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system | Q37904374 | ||
| Beyond RNAi: antiviral defense strategies in Drosophila and mosquito | Q38028736 | ||
| Chikungunya virus: an update on antiviral development and challenges | Q38107673 | ||
| Temporal SILAC-based quantitative proteomics identifies host factors involved in chikungunya virus replication. | Q38415017 | ||
| Chikungunya: Evolutionary history and recent epidemic spread | Q38483795 | ||
| Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus | Q38895828 | ||
| The occurrence of Chikungunya virus in Uganda. I. Isolation from mosquitoes | Q38899220 | ||
| Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral | Q38982527 | ||
| Seroprevalence of dengue, chikungunya and Sindbis virus infections in German aid workers | Q38983563 | ||
| Use of human monoclonal antibodies to treat Chikungunya virus infection | Q39012242 | ||
| Chikungunya virus nsP3 & nsP4 interacts with HSP-90 to promote virus replication: HSP-90 inhibitors reduce CHIKV infection and inflammation in vivo. | Q39037522 | ||
| Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus | Q39299364 | ||
| An imported case of Chikungunya fever from Madagascar: use of the sentinel traveller for detecting emerging arboviral infections in tropical and European countries | Q39358394 | ||
| Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial | Q39382188 | ||
| Mapping of Chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral component | Q39410121 | ||
| Epidemic resurgence of Chikungunya virus in democratic Republic of the Congo: identification of a new central African strain | Q39693095 | ||
| Seroprevalence and distribution of Flaviviridae, Togaviridae, and Bunyaviridae arboviral infections in rural Cameroonian adults. | Q39757948 | ||
| Chikungunya outbreak in Montpellier, France, September to October 2014. | Q40156908 | ||
| Chikungunya virus non-structural protein 2-mediated host shut-off disables the unfolded protein response | Q40182946 | ||
| Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe | Q40210825 | ||
| Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013. | Q40210836 | ||
| Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infection | Q40217985 | ||
| Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits | Q40232449 | ||
| Cytokine levels in patients with chikungunya virus infection | Q40243475 | ||
| A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus | Q40245153 | ||
| Antiviral chlorinated daphnane diterpenoid orthoesters from the bark and wood of Trigonostemon cherrieri | Q40275796 | ||
| Cluster of chikungunya virus infection in travelers returning from Senegal, 2006. | Q40382482 | ||
| An outbreak of yellow fever with concurrent chikungunya virus transmission in South Kordofan, Sudan, 2005. | Q40418405 | ||
| Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. | Q40427692 | ||
| Circulation of Chikungunya virus in Gabon, 2006-2007. | Q40429258 | ||
| Chikungunya fever as a risk factor for endemic Burkitt's lymphoma in Malawi | Q40607929 | ||
| Seroprevalence of five arboviruses in Zebu cattle in the Central African Republic | Q40675363 | ||
| Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial | Q42199381 | ||
| Chikungunya virus capsid protein contains nuclear import and export signals | Q42273688 | ||
| The C-terminal domain of chikungunya virus nsP2 independently governs viral RNA replication, cytopathicity, and inhibition of interferon signaling | Q42283124 | ||
| Chikungunya disease outbreak, Reunion Island. | Q42616934 | ||
| P433 | issue | 4 | |
| P921 | main subject | chikungunya | Q243257 |
| pathogenesis | Q372016 | ||
| Chikungunya virus | Q15794049 | ||
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | e107-e117 | |
| P577 | publication date | 2017-01-31 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen | |
| P478 | volume | 17 |
| Q63740168 | -Chikungunya Virus Interaction: Key Role of Vector Midguts Microbiota and Its Saliva in the Host Infection |
| Q92298823 | A new multiplex RT-qPCR method for the simultaneous detection and discrimination of Zika and chikungunya viruses |
| Q90308853 | A potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and Dengue viruses |
| Q47547858 | Aedes Mosquitoes and Aedes-Borne Arboviruses in Africa: Current and Future Threats. |
| Q63246358 | An epidemic of chikungunya in northwestern Bangladesh in 2011 |
| Q89794663 | Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection |
| Q64374730 | Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus |
| Q60956543 | Assessment of metagenomic Nanopore and Illumina sequencing for recovering whole genome sequences of chikungunya and dengue viruses directly from clinical samples |
| Q62485127 | Atovaquone inhibits arbovirus replication through the depletion of intracellular nucleotides |
| Q93161303 | Beyond Fever and Pain: Diagnostic Methods for Chikungunya Virus |
| Q58575620 | Cellular and Molecular Immune Response to Chikungunya Virus Infection |
| Q91919693 | Chikungunya Fever Outbreak, Zhejiang Province, China, 2017 |
| Q41931672 | Chikungunya Virus Infection: Why Should U.S. Geriatricians Be Aware of It? |
| Q41923135 | Chikungunya Virus-Associated Disease |
| Q59360387 | Chikungunya fever: a threat to global public health |
| Q55495698 | Chikungunya outbreak (2017) in Bangladesh: Clinical profile, economic impact and quality of life during the acute phase of the disease. |
| Q89899047 | Chikungunya virus evades antiviral CD8+ T cell responses to establish persistent infection in joint-associated tissues |
| Q63246354 | Chikungunya virus infection in Indonesia: a systematic review and evolutionary analysis |
| Q93099302 | Chikungunya virus requires cellular chloride channels for efficient genome replication |
| Q47098677 | Chikungunya: vaccines and therapeutics |
| Q91354673 | Comparative study of chikungunya Virus-Like Particles and Pseudotyped-Particles used for serological detection of specific immunoglobulin M |
| Q90083437 | Complete Coding Sequence of a Chikungunya Virus Strain Imported into Slovenia from Thailand in Late 2018 |
| Q56965879 | Comprehensive innate immune profiling of chikungunya virus infection in pediatric cases |
| Q92061425 | Conducta práctica ante un niño febril al regresar de un viaje |
| Q93271332 | Conduite à tenir devant un enfant fébrile au retour de voyage |
| Q58569806 | Conserved motifs in the hypervariable domain of chikungunya virus nsP3 required for transmission by Aedes aegypti mosquitoes |
| Q94561515 | Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections |
| Q54218397 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. |
| Q90736522 | Dengue, Zika and chikungunya during pregnancy: pre- and post-travel advice and clinical management |
| Q66678852 | Distinguishing patients with laboratory-confirmed chikungunya from dengue and other acute febrile illnesses, Puerto Rico, 2012-2015 |
| Q64089980 | Emergent Arboviruses and Renal Transplantation: A Global Challenge |
| Q92648804 | Emerging and threatening vector-borne zoonoses in the world and in Europe: a brief update |
| Q56396145 | Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus |
| Q98461002 | Evaluation of novobiocin and telmisartan for anti-CHIKV activity |
| Q90289089 | FHL1 is a major host factor for chikungunya virus infection |
| Q92454880 | Genetic Variability of Chikungunya Virus in Southern Mexico |
| Q89899063 | High-throughput fluorescence-based screen identifies the neuronal microRNA miR-124 as a positive regulator of alphavirus infection |
| Q47557749 | How Do Virus-Mosquito Interactions Lead to Viral Emergence? |
| Q91725203 | Importance of microenvironment to arbovirus vector distribution in an urban area, São Paulo, Brazil |
| Q91899306 | Inhibition of Chikungunya Virus Replication in Primary Human Fibroblasts by Liver X Receptor Agonist |
| Q36400444 | Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders: A systematic review |
| Q54215277 | Molecular and Clinical Characterization of Chikungunya Virus Infections in Southeast Mexico. |
| Q52558441 | Mutation of CD2AP and SH3KBP1 Binding Motif in Alphavirus nsP3 Hypervariable Domain Results in Attenuated Virus. |
| Q95276844 | NMDAR Encephalitis Associated With Acute Chikungunya Virus Infection: A New Trigger? |
| Q89820612 | Neutrophil Extracellular Traps Effectively Control Acute Chikungunya Virus Infection |
| Q40225114 | New viral outbreaks: time for rheumatologists to get involved? |
| Q90417587 | Overproduction of IL-6 and Type-I IFN in a Lethal Case of Chikungunya Virus Infection in an Elderly Man During the 2017 Italian Outbreak |
| Q59354762 | Preparation of Recombinant Alphaviruses for Functional Studies of ADP-Ribosylation |
| Q40117821 | Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology |
| Q55273724 | Rapid identification of medically important mosquitoes by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. |
| Q60053843 | Rev-erb Agonist Inhibits Chikungunya and O'nyong'nyong Virus Replication |
| Q93087252 | Rheumatic manifestations of chikungunya: emerging concepts and interventions |
| Q49803948 | Spindle-E Acts Antivirally Against Alphaviruses in Mosquito Cells |
| Q47139845 | Successful Live Kidney Transplantation After Chikungunya Disease in the Donor |
| Q93042869 | Synergistic terpene combinations as larvicides against the dengue vector Aedes aegypti Linn |
| Q66679599 | Systems analysis of subjects acutely infected with the Chikungunya virus |
| Q56988192 | The Interplay of Viral and Host Factors in Chikungunya Virus Infection: Targets for Antiviral Strategies |
| Q57091919 | The Surveillance of Chikungunya Virus in a Temperate Climate: Challenges and Possible Solutions from the Experience of Lazio Region, Italy |
| Q55359786 | The containment of potential outbreaks triggered by imported Chikungunya cases in Italy: a cost utility epidemiological assessment of vector control measures. |
| Q62737885 | Tropism of the Chikungunya Virus |
| Q41924875 | Ubiquitin-Conjugating Enzyme E2 L3 is Downregulated by the Chikungunya Virus nsP2 Protease |
| Q30145569 | Uncovering the repertoire of endogenous flaviviral elements in Aedes mosquito genomes |
| Q54206944 | Use of Bead-Based Serologic Assay to Evaluate Chikungunya Virus Epidemic, Haiti. |
| Q90622234 | [Exanthema after travel abroad] |
Search more.